To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DYNC2LI1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
288 supporting clones for gene DYNC2LI1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CD101797 Blood vessels - aorta, basilar and artery .a 1 to 734 1 to 735   tiling clone,   735/736
(99 %)
7 diff
(99.1 %id)
AA436543 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 308 to 781 11 to 481       471/481
(97 %)
8 diff
(98.4 %id)
BG503193 embryonal carcinoma, testis .a 626 to 1369 1 to 750   tiling clone,   750/752
(99 %)
22 diff
(97.1 %id)
AA436488 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1041 to 1176 136 to 1       136/136
(100 %)
0 diff
(100 %id)
NM_001193464.1   .b 1 to 1400 1 to 1400 exact RefSeq, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 1400/1400
(100 %)
0 diff
(100 %id)
BP368873 testis .b 1 to 576 1 to 576   tiling clone,   576/576
(100 %)
1 diff
(99.9 %id)
BF207489 bladder, carcinoma, cell line .b 5 to 652 1 to 641       641/885
(72 %)
19 diff
(97.9 %id)
AL702718 human skeletal muscle .b 7 to 563 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BF241588 bone marrow, from acute myelogenous leukemia .b 8 to 528 1 to 537       515/586
(87 %)
45 diff
(92.4 %id)
BP873236 embryonal kidney .b 10 to 326 1 to 318       318/333
(95 %)
9 diff
(97.3 %id)
AU100399   .b 11 to 310 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
AU102391   .b 11 to 60 1 to 50       50/50
(100 %)
2 diff
(96.0 %id)
DA173969 amygdala .b 12 to 560 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
BG616443 Liver .b 15 to 662 1 to 656       656/795
(82 %)
12 diff
(98.5 %id)
BQ429355 testis .b 15 to 328 1 to 315       315/646
(48 %)
7 diff
(99.0 %id)
BI439099 Pancreas, Purified pancreatic islet .b 16 to 617 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
BF669861 brain, primitive neuroectoderm .b 16 to 599 1 to 586       586/837
(70 %)
21 diff
(97.5 %id)
BG535376 lung .b 16 to 792 1 to 782       782/783
(99 %)
16 diff
(98.0 %id)
CD699769 normal nasopharynx .b 17 to 421 21 to 426       406/427
(95 %)
11 diff
(97.5 %id)
DB488831 hypothalamus .b 17 to 471 1 to 455       455/455
(100 %)
4 diff
(99.2 %id)
BG432523 Kidney .b 17 to 648 1 to 633       633/633
(100 %)
4 diff
(99.4 %id)
BF696639 brain, primitive neuroectoderm .b 18 to 608 1 to 592       592/858
(68 %)
21 diff
(97.6 %id)
DA375608 thalamus .b 19 to 589 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
BP367130 thymus .b 22 to 606 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BM764146 myeloma .b 23 to 594 1 to 572       572/572
(100 %)
0 diff
(100 %id)
AL559072 T cells from T cell leukemia .b 28 to 544 1 to 518       518/518
(100 %)
2 diff
(99.7 %id)
BE830582 marrow .b 36 to 227 211 to 19       191/229
(83 %)
0 diff
(100 %id)
BE737976 brain, glioblastoma .b 37 to 607 1 to 567       567/885
(64 %)
10 diff
(98.9 %id)
EL948747 eyeball .b 38 to 607 1 to 571       571/577
(98 %)
8 diff
(98.7 %id)
AA312584   .b 39 to 420 1 to 383       383/383
(100 %)
2 diff
(99.5 %id)
AW958684   .b 40 to 421 1 to 384       384/432
(88 %)
21 diff
(95.2 %id)
BG431470 Kidney .b 41 to 597 1 to 557       557/560
(99 %)
4 diff
(99.3 %id)
BC006969 Kidney, hypernephroma .b 42 to 1389 1 to 1348 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 1348/1348
(100 %)
1 diff
(100.0 %id)
DT220106 brain .b 42 to 658 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
BG401011 Kidney .b 42 to 607 1 to 569       569/849
(67 %)
8 diff
(99.1 %id)
CB112724 Liver .b 43 to 676 1 to 634       634/634
(100 %)
0 diff
(100 %id)
DN997904 breast cancer, Mammary gland (cancer tissue) .b 43 to 487 1 to 444       444/444
(100 %)
5 diff
(98.9 %id)
BF687906 brain, glioblastoma .b 45 to 607 1 to 571       571/786
(72 %)
28 diff
(96.5 %id)
AV684747 hepatocellular carcinoma .b 54 to 478 1 to 416       412/419
(98 %)
8 diff
(98.1 %id)
AV686974 hepatocellular carcinoma .b 54 to 500 1 to 438       438/438
(100 %)
11 diff
(97.5 %id)
AV688085 hepatocellular carcinoma .b 54 to 453 1 to 390       395/390
(101 %)
9 diff
(97.7 %id)
AV689002 hepatocellular carcinoma .b 54 to 453 1 to 390       390/390
(100 %)
7 diff
(98.3 %id)
AV692371 hepatocellular carcinoma .b 54 to 453 1 to 390       395/390
(101 %)
9 diff
(97.7 %id)
DB502700 hypothalamus .b 59 to 542 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
BF031024 hypernephroma, Kidney .b 61 to 674 1 to 608       608/617
(98 %)
10 diff
(98.4 %id)
BU197030 ductal carcinoma, cell line, Pancreas .b 63 to 879 1 to 823       821/925
(88 %)
12 diff
(98.8 %id)
TI_1948122749   .b 101 to 658 119 to 676   fully sequenced,   558/676
(82 %)
1 diff
(99.9 %id)
TI_1948122887   .b 101 to 638 119 to 658   fully sequenced,   540/635
(85 %)
4 diff
(99.4 %id)
TI_1948123041   .b 101 to 510 122 to 535   fully sequenced,   414/515
(80 %)
5 diff
(99.1 %id)
TI_1948123187   .b 101 to 555 110 to 564   fully sequenced,   455/547
(83 %)
7 diff
(98.8 %id)
TI_1948220806   .b 101 to 518 137 to 554       418/446
(93 %)
1 diff
(99.8 %id)
CD701318 normal nasopharynx .b 107 to 468 56 to 417       362/417
(86 %)
6 diff
(98.6 %id)
CV027395 mixed .b 107 to 753 7 to 653       647/653
(99 %)
6 diff
(99.1 %id)
BF790077 muscle (skeletal) .b 152 to 533 1 to 387       387/387
(100 %)
10 diff
(97.5 %id)
AV711639   .b 176 to 906 1 to 723       723/741
(97 %)
27 diff
(96.4 %id)
FN169829 breast carcinoma .b 198 to 312 1 to 116       116/116
(100 %)
2 diff
(98.3 %id)
FN052190 breast carcinoma .b 415 to 517 103 to 1     Submitted on the opposite strand 103/108
(95 %)
4 diff
(96.3 %id)
FN139052 breast carcinoma .b 437 to 541 1 to 106       106/106
(100 %)
1 diff
(99.1 %id)
TI_1948123042   .b 480 to 1167 800 to 114   fully sequenced,   687/800
(85 %)
0 diff
(100 %id)
TI_1948123188   .b 525 to 1168 752 to 109   fully sequenced,   644/752
(85 %)
7 diff
(99.1 %id)
TI_1948122888   .b 603 to 1168 620 to 55   fully sequenced,   566/620
(91 %)
3 diff
(99.6 %id)
TI_1948122750   .b 628 to 1167 649 to 111   fully sequenced,   539/649
(83 %)
0 diff
(100 %id)
BE738285 brain, glioblastoma .b 647 to 1284 638 to 2       637/638
(99 %)
0 diff
(100 %id)
AI760932 2 pooled tumors (clear cell type), Kidney .b 650 to 1391 750 to 9       742/750
(98 %)
2 diff
(99.8 %id)
TI_149278038   .b 690 to 1394 789 to 84   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 706/707
(99 %)
3 diff
(99.6 %id)
CB250568 Human Lung Epithelial cells, lung .b 701 to 1394 710 to 19   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 692/694
(99 %)
6 diff
(99.2 %id)
AA464822   .b 703 to 1127 1 to 425   fully sequenced,   425/425
(100 %)
1 diff
(99.8 %id)
BU678170 lung .b 710 to 1394 704 to 19   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 686/686
(100 %)
3 diff
(99.6 %id)
BI258054 cervical carcinoma cell line, cervix .b 712 to 1391 1 to 681       678/697
(97 %)
21 diff
(97.0 %id)
BI261230 cervical carcinoma cell line, cervix .b 722 to 1360 58 to 712       654/816
(80 %)
42 diff
(94.9 %id)
FN047704 breast carcinoma .b 728 to 827 100 to 1     Submitted on the opposite strand 100/100
(100 %)
0 diff
(100 %id)
AI755075 bone marrow stroma .b 745 to 1390 664 to 19   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 646/646
(100 %)
2 diff
(99.7 %id)
AA385824 thyroid gland .b 751 to 1070 1 to 322       322/322
(100 %)
5 diff
(98.5 %id)
CN480411 Knee, Osteoarthritic Cartilage .b 765 to 1400 655 to 19   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 637/637
(100 %)
3 diff
(99.6 %id)
AV723507 hypothalamus .b 771 to 1349 597 to 27     Submitted on the opposite strand 571/601
(95 %)
5 diff
(99.2 %id)
AW195522 Kidney .b 791 to 1402 627 to 1       627/627
(100 %)
24 diff
(96.2 %id)
BI438780 Pancreas, Purified pancreatic islet .b 803 to 1400 598 to 1       598/598
(100 %)
1 diff
(99.9 %id)
BE326729 Kidney .b 822 to 1390 568 to 1       568/568
(100 %)
1 diff
(99.9 %id)
BF438343 Prostate .b 827 to 1394 579 to 12   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 568/568
(100 %)
1 diff
(99.9 %id)
AI279515 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 829 to 1394 566 to 1       566/566
(100 %)
1 diff
(99.9 %id)
FN051756 breast carcinoma .b 904 to 977 1 to 74       74/75
(98 %)
1 diff
(98.7 %id)
FN148593 breast carcinoma .b 999 to 1091 1 to 93       93/93
(100 %)
0 diff
(100 %id)
AA450294   .b 1066 to 1400 335 to 1   fully sequenced,   335/335
(100 %)
0 diff
(100 %id)
AW947332 lung_tumor .b 1096 to 1289 195 to 1     Submitted on the opposite strand 195/239
(81 %)
9 diff
(96.3 %id)
AA714026 germinal center B cell .b 1096 to 1394 312 to 16   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 297/302
(98 %)
2 diff
(99.4 %id)
AA860096   .b 1096 to 1395 302 to 3       300/307
(97 %)
0 diff
(100 %id)
BG716986 testis .c 1 to 632 1 to 632       632/632
(100 %)
4 diff
(99.4 %id)
BX493698   .c 4 to 772 1 to 770       770/770
(100 %)
7 diff
(99.1 %id)
AK223432 testis .c 6 to 1402 1 to 1397 F33S I230L tiling clone, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 1397/1397
(100 %)
3 diff
(99.8 %id)
NM_016008.3   .c 6 to 1402 1 to 1397 exact RefSeq, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 1397/1397
(100 %)
0 diff
(100 %id)
BP382585 adipose tissue .c 16 to 641 1 to 626       626/626
(100 %)
4 diff
(99.4 %id)
AK074206 adipose tissue .c 16 to 1396 1 to 1381 exact available from FLJ, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 1381/1381
(100 %)
1 diff
(100.0 %id)
DA732766   .c 17 to 682 2 to 670   capped   669/745
(89 %)
8 diff
(99.0 %id)
BU194353 bone marrow, from acute myelogenous leukemia .c 19 to 776 1 to 759       759/760
(99 %)
7 diff
(99.1 %id)
BF976846 melanotic melanoma, high MDR, skin .c 21 to 756 1 to 730       731/886
(82 %)
41 diff
(95.4 %id)
BF184916 bone marrow, from chronic myelogenous leukemia .c 27 to 675 1 to 648       645/864
(74 %)
11 diff
(98.8 %id)
BI091532 cervix .c 27 to 674 1 to 650       650/853
(76 %)
11 diff
(98.8 %id)
BG723760 testis .c 28 to 684 1 to 657       657/657
(100 %)
4 diff
(99.4 %id)
BQ637479 eye, retina .c 30 to 646 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
BF697774 brain, primitive neuroectoderm .c 30 to 674 1 to 650       650/877
(74 %)
26 diff
(97.1 %id)
BG494926 lung, mucoepidermoid carcinoma .c 32 to 673 1 to 642       642/642
(100 %)
5 diff
(99.3 %id)
CR600166 T cells (Jurkat cell line) Cot10-normalized .c 33 to 1356 1 to 1324 exact     1324/1324
(100 %)
0 diff
(100 %id)
TI_57175840   .c 33 to 963 65 to 989       925/989
(93 %)
21 diff
(97.9 %id)
BI829109 brain, medulla .c 37 to 963 1 to 921       921/921
(100 %)
15 diff
(98.4 %id)
BU521477 leiomyosarcoma, uterus .c 40 to 884 1 to 856       854/889
(96 %)
10 diff
(98.9 %id)
AF151818   .c 44 to 1402 1 to 1355 N163Y M164A P165E K166D D167H ... AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 1355/1355
(100 %)
3 diff
(99.8 %id)
CB985781 Pooled-Glandular .c 44 to 777 1 to 738       738/740
(99 %)
12 diff
(98.4 %id)
BG252549 adenocarcinoma, cell line, Liver .c 45 to 794 1 to 744       744/748
(99 %)
7 diff
(99.1 %id)
AY083346   .c 46 to 1396 1 to 1351 exact tiling clone, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 1351/1351
(100 %)
0 diff
(100 %id)
BG547655 lung .c 46 to 810 1 to 758       758/790
(95 %)
14 diff
(98.3 %id)
BQ432334 leiomyosarcoma, uterus .c 52 to 964 1 to 913       913/913
(100 %)
7 diff
(99.3 %id)
BX642950   .c 53 to 648 10 to 605       596/605
(98 %)
7 diff
(98.9 %id)
BG717781 testis .c 53 to 716 1 to 664       664/669
(99 %)
4 diff
(99.5 %id)
BG772122 testis .c 53 to 836 1 to 786       786/903
(87 %)
13 diff
(98.6 %id)
CN363763 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 56 to 806 1 to 751       751/751
(100 %)
5 diff
(99.4 %id)
BI596694 brain, hypothalamus .c 57 to 987 1 to 934       932/944
(98 %)
37 diff
(96.1 %id)
BI668827 brain, hypothalamus .c 57 to 857 1 to 800       800/801
(99 %)
12 diff
(98.6 %id)
AV698821 hepatocellular carcinoma .c 59 to 677 1 to 612       612/646
(94 %)
10 diff
(98.5 %id)
TI_45209122   .c 62 to 987 90 to 1018       927/1028
(90 %)
39 diff
(96.3 %id)
TI_44345533   .c 62 to 857 90 to 884       795/885
(89 %)
14 diff
(98.5 %id)
CR622142 Placenta Cot 25-normalized .c 67 to 1365 1 to 1299 exact     1299/1299
(100 %)
0 diff
(100 %id)
AL553019 placenta, Placenta Cot 25-normalized .c 67 to 790 1 to 722   fully sequenced,   722/722
(100 %)
1 diff
(99.9 %id)
BG654491 Pancreas, Purified pancreatic islet .c 73 to 648 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
CN363767 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 77 to 804 1 to 727       727/727
(100 %)
2 diff
(99.8 %id)
BM023467 Islets of Langerhans, Pancreas .c 80 to 663 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BE972564 testis .c 89 to 682 1 to 594       592/729
(81 %)
32 diff
(95.7 %id)
BP369274 testis .c 90 to 670 1 to 579       579/580
(99 %)
6 diff
(99.0 %id)
CU454506 epidermis .c 146 to 836 717 to 27     Submitted on the opposite strand 692/717
(96 %)
4 diff
(99.5 %id)
AI908482 breast .c 197 to 836 676 to 34       640/677
(94 %)
8 diff
(98.9 %id)
CN363765 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 309 to 1028 1 to 719       719/719
(100 %)
2 diff
(99.8 %id)
BX391903   .c 340 to 1205 873 to 1       873/921
(94 %)
20 diff
(97.9 %id)
BU162322 eye, retinoblastoma .c 370 to 1274 1 to 904       904/905
(99 %)
9 diff
(99.1 %id)
BQ787216 Pancreas, Purified pancreatic islet .c 387 to 938 1 to 552   fully sequenced,   552/552
(100 %)
0 diff
(100 %id)
BQ441589 testis .c 409 to 836 1 to 428       428/934
(45 %)
3 diff
(99.7 %id)
AA476487   .c 462 to 988 1 to 525       525/527
(99 %)
3 diff
(99.5 %id)
AL576128 placenta, Placenta Cot 25-normalized .c 729 to 1365 639 to 1   fully sequenced,   639/639
(100 %)
2 diff
(99.7 %id)
BM023185 Islets of Langerhans, Pancreas .c 808 to 1397 595 to 6       590/595
(99 %)
0 diff
(100 %id)
DB364389   .c 841 to 1392 547 to 1       547/579
(94 %)
10 diff
(98.3 %id)
BQ786938 Pancreas, Purified pancreatic islet .c 877 to 1391 515 to 1   fully sequenced,   515/515
(100 %)
0 diff
(100 %id)
AL520329 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 1 to 1057 2 to 1047   tiling clone,   1047/1103
(94 %)
22 diff
(98.1 %id)
BC035126 Brain, hippocampus .d 1069 to 3569 1 to 2502   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 2502/2502
(100 %)
4 diff
(99.9 %id)
BI549463 brain, hippocampus .d 1069 to 1954 1 to 882   available from MGC,   882/953
(92 %)
20 diff
(98.0 %id)
TI_44169285   .d 1072 to 1954 126 to 1004       879/1075
(81 %)
6 diff
(99.5 %id)
DB474958 hippocampus .d 1074 to 1567 1 to 494       494/494
(100 %)
0 diff
(100 %id)
AI758499 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1130 to 1381 256 to 5       252/256
(98 %)
0 diff
(100 %id)
AI275414 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1134 to 1381 252 to 5       248/252
(98 %)
0 diff
(100 %id)
AI342230 uterus .d 1134 to 1387 254 to 1       254/254
(100 %)
0 diff
(100 %id)
AW102583 pooled .d 1134 to 1380 270 to 24   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 247/247
(100 %)
9 diff
(96.4 %id)
BX642925   .d 1446 to 2025 11 to 590       580/590
(98 %)
6 diff
(99.0 %id)
DB150970 thymus .d 2106 to 2691 2 to 590   capped   589/589
(100 %)
3 diff
(99.5 %id)
FN086935 breast carcinoma .d 2406 to 2468 63 to 1     Submitted on the opposite strand 63/63
(100 %)
0 diff
(100 %id)
AL520328 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 2496 to 3531 1032 to 1   tiling clone,   1032/1069
(96 %)
21 diff
(98.1 %id)
DR423413 eye, Pterygium .d 2497 to 3245 1 to 749       749/749
(100 %)
6 diff
(99.2 %id)
DB492618 hypothalamus .d 3373 to 3815 1 to 442   tiling clone,   442/442
(100 %)
23 diff
(94.8 %id)
DB492977 hypothalamus .d 3374 to 3798 1 to 425   tiling clone,   425/440
(96 %)
19 diff
(95.7 %id)
AI864553 anaplastic oligodendroglioma, brain .d 3623 to 4090 472 to 1       472/474
(99 %)
14 diff
(97.1 %id)
AW470694 2 pooled tumors (clear cell type), Kidney .d 3652 to 4095 444 to 1   tiling clone,   444/444
(100 %)
0 diff
(100 %id)
CD104672 Pooled-Skin .d 4680 to 5345 1 to 667   tiling clone,   667/739
(90 %)
3 diff
(99.6 %id)
DB346126 thymus .d 5290 to 5830 543 to 1   tiling clone,   543/543
(100 %)
2 diff
(99.7 %id)
DB563692 hypothalamus .d 5389 to 5823 1 to 434     Submitted on the opposite strand 434/435
(99 %)
7 diff
(98.4 %id)
DB539690 hippocampus .d 5409 to 5827 1 to 420     Submitted on the opposite strand 420/421
(99 %)
9 diff
(97.9 %id)
BE048053 brain, tumor, 5 pooled (see description) .d 5429 to 5834 1 to 406   tiling clone, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 406/406
(100 %)
2 diff
(99.6 %id)
AL050006 brain .e 1 to 1254 1 to 1252 I13F F17S I214L tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1252/1252
(100 %)
7 diff
(99.5 %id)
AI739566 colon, colon tumor, RER+ .e 470 to 990 521 to 1   tiling clone,   521/524
(99 %)
0 diff
(100 %id)
BF681415 Prostate .e 641 to 1253 1 to 615   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 615/615
(100 %)
7 diff
(98.9 %id)
AI809986 pooled .e 649 to 990 342 to 1       342/342
(100 %)
0 diff
(100 %id)
AW169765 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 771 to 1123 354 to 2       353/354
(99 %)
0 diff
(100 %id)
BX105321 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 802 to 1254 467 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 453/453
(100 %)
0 diff
(100 %id)
AI985163 Kidney .e 814 to 990 177 to 1       177/177
(100 %)
0 diff
(100 %id)
BM702544 eye, human retina .f 1 to 550 1 to 550   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 550/550
(100 %)
1 diff
(99.9 %id)
BM665257 eye, human retina .f 489 to 1004 535 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 517/517
(100 %)
2 diff
(99.7 %id)
AK301489 synovial membrane tissue from rheumatoidarthritis .g 1 to 1084 2 to 1085 H11R tiling clone,   1085/1085
(100 %)
2 diff
(99.9 %id)
DA993020 synovial membrane tissue from rheumatioidarthritis .g 1 to 567 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
AA188253   .g 44 to 232 1 to 189       189/189
(100 %)
4 diff
(97.9 %id)
AA186610   .g 870 to 1311 444 to 1   tiling clone,   444/444
(100 %)
2 diff
(99.6 %id)
NM_015522.3   .h 1 to 1139 1 to 1139 exact RefSeq, AAA   1139/1139
(100 %)
0 diff
(100 %id)
BC016324 Bladder, carcinoma .h 11 to 1137 5 to 1131 exact tiling clone, available from MGC, AAA   1127/1127
(100 %)
1 diff
(100.0 %id)
BI462877 testis .h 24 to 822 1 to 777 E31K F33L V34F F35L F36H ... AAA   777/863
(90 %)
40 diff
(95.4 %id)
BF244579 brain, glioblastoma .h 26 to 665 1 to 638       638/638
(100 %)
10 diff
(98.5 %id)
BC058823 Brain, glioblastoma .h 38 to 1139 5 to 1106 P58S available from MGC, AAA   1102/1102
(100 %)
2 diff
(99.9 %id)
BQ432717 testis .h 54 to 789 1 to 749 F33S V182A F184Y N187Y F195L ...     749/842
(88 %)
29 diff
(96.6 %id)
BG428611 Kidney .h 59 to 773 1 to 706 N76K T77H P78Q D80I I81S ...     706/706
(100 %)
13 diff
(98.2 %id)
TI_1948152996   .h 101 to 699 132 to 731   fully sequenced,   600/628
(95 %)
5 diff
(99.3 %id)
TI_1948153123   .h 101 to 706 132 to 734 L198M C199H M200D T201L fully sequenced,   603/631
(95 %)
2 diff
(99.7 %id)
TI_1948153405   .h 101 to 715 134 to 748 K166E D167G H168S P169S V170C ... fully sequenced,   615/748
(82 %)
13 diff
(98.3 %id)
TI_1948220976   .h 101 to 451 131 to 481   fully sequenced,   351/379
(92 %)
1 diff
(99.8 %id)
TI_1948221147   .h 101 to 362 132 to 393   fully sequenced,   262/290
(90 %)
1 diff
(99.7 %id)
TI_1948221313   .h 101 to 362 128 to 389   fully sequenced,   262/290
(90 %)
1 diff
(99.7 %id)
CN363766 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 102 to 718 1 to 617       617/617
(100 %)
7 diff
(98.9 %id)
EL735821 mixed .h 107 to 697 7 to 597       591/597
(98 %)
7 diff
(98.9 %id)
TI_1948153272   .h 107 to 706 137 to 737       601/652
(92 %)
11 diff
(98.4 %id)
TI_1948153406   .h 301 to 706 538 to 133   fully sequenced,   406/538
(75 %)
0 diff
(100 %id)
TI_1948221148   .h 301 to 705 528 to 124   fully sequenced,   405/528
(76 %)
0 diff
(100 %id)
TI_1948221314   .h 301 to 706 532 to 128   fully sequenced,   405/532
(76 %)
0 diff
(100 %id)
TI_1948153124   .h 361 to 706 476 to 134   fully sequenced,   343/476
(72 %)
2 diff
(99.6 %id)
BQ575687 Chondrosarcoma Grade II, Left Pelvis .h 381 to 1088 726 to 19   AAA   708/708
(100 %)
4 diff
(99.5 %id)
TI_1948220977   .h 390 to 706 440 to 125   fully sequenced,   316/343
(92 %)
0 diff
(100 %id)
TI_1948152997   .h 583 to 712 250 to 122   fully sequenced,   129/150
(86 %)
5 diff
(96.7 %id)
BI463982 testis .i 1 to 647 5 to 651 exact available from MGC,   651/651
(100 %)
5 diff
(99.3 %id)
DA699829   .i 1 to 481 2 to 482   tiling clone, capped   481/482
(99 %)
1 diff
(99.8 %id)
BC040558 testis .i 2 to 2903 1 to 2902 exact tiling clone, available from MGC, AAA   2902/2902
(100 %)
5 diff
(99.9 %id)
TI_1948236780   .i 78 to 510 1041 to 603     Submitted on the opposite strand 439/1286
(34 %)
15 diff
(98.9 %id)
EL737186 mixed .i 83 to 510 7 to 434       428/592
(72 %)
7 diff
(98.9 %id)
TI_1948236779   .i 230 to 510 889 to 609     Submitted on the opposite strand 281/1434
(19 %)
7 diff
(99.6 %id)
H41091 eye, retina .i 2072 to 2538 1 to 464   tiling clone, Submitted on the opposite strand 464/465
(99 %)
11 diff
(97.7 %id)
CA843794 Pancreas, Purified pancreatic islet .i 2287 to 2900 614 to 1   tiling clone,   614/614
(100 %)
4 diff
(99.4 %id)
CB528979 Aveolar Macrophage, lung .i 2320 to 2896 596 to 19   AAA   578/578
(100 %)
2 diff
(99.7 %id)
AI478267 Kidney .i 2438 to 2898 461 to 1       461/461
(100 %)
0 diff
(100 %id)
GD143698   .i 2454 to 2546 1 to 93       93/97
(95 %)
5 diff
(94.9 %id)
DA382708 thalamus .j-u 1 to 564 2 to 567   tiling clone, capped   566/566
(100 %)
2 diff
(99.7 %id)
EB386155 eye, optic nerve .j-u 535 to 1351 1 to 819   tiling clone,   819/819
(100 %)
2 diff
(99.8 %id)
DB311501 thalamus .j-u 1960 to 2248 293 to 1   tiling clone,   293/293
(100 %)
5 diff
(98.3 %id)
DA100016 cerebellum .k 1 to 543 2 to 545   tiling clone, capped   544/544
(100 %)
14 diff
(97.5 %id)
AA331764 Embryo, 8 weeks .k 87 to 368 1 to 284   tiling clone,   284/284
(100 %)
3 diff
(99.0 %id)
DA103297 cerebellum .k 162 to 703 2 to 543   tiling clone, capped   542/542
(100 %)
0 diff
(100 %id)
DB231940 trachea .k 305 to 910 2 to 607   tiling clone, capped   606/606
(100 %)
0 diff
(100 %id)
DB299044 cerebellum .k 1728 to 2162 438 to 1 W4* tiling clone,   438/438
(100 %)
7 diff
(98.5 %id)
AW131874 brain, medulloblastoma .l 103 to 573 1 to 472   tiling clone, Submitted on the opposite strand 472/472
(100 %)
1 diff
(99.8 %id)
DA810460 brain .l 161 to 720 2 to 561   tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
AI341556   .l 506 to 1095 596 to 7 exact tiling clone,   590/596
(98 %)
0 diff
(100 %id)
BE999927 colon, colon tumor, RER+ .l 518 to 847 329 to 1       329/391
(84 %)
20 diff
(94.9 %id)
BX334118 Neuroblastoma Cot 50-normalized .l 525 to 1084 1 to 560 E9X S58F S66F     560/560
(100 %)
6 diff
(99.0 %id)
AL580772 T cells from T cell leukemia .l 526 to 1047 523 to 1 V7S Y8V E9*     523/523
(100 %)
8 diff
(98.5 %id)
AW271489 Kidney .l 526 to 1095 576 to 7 exact     570/581
(98 %)
1 diff
(99.9 %id)
BG654559 Pancreas, Purified pancreatic islet .l 541 to 1087 547 to 1 exact   Submitted on the opposite strand 547/547
(100 %)
5 diff
(99.1 %id)
BF434835 Kidney .l 541 to 1086 545 to 1 exact     545/545
(100 %)
2 diff
(99.7 %id)
AW271612 Kidney .l 544 to 1088 546 to 2 exact     545/546
(99 %)
0 diff
(100 %id)
AW341090 carcinoid, lung .l 544 to 1095 553 to 2 exact     552/553
(99 %)
1 diff
(99.9 %id)
AW592733 pooled .l 544 to 1086 548 to 6 exact     543/548
(99 %)
0 diff
(100 %id)
BG220635   .l 553 to 1088 13 to 549 exact     537/582
(92 %)
18 diff
(97.0 %id)
BE349047 malignant melanoma, metastatic to lymphnode, skin .l 564 to 1087 524 to 1 exact     524/524
(100 %)
0 diff
(100 %id)
AA224467 brain, neuroepithelial cells .l 598 to 1089 501 to 3 V7G Y8V E9*     499/522
(95 %)
8 diff
(98.5 %id)
AI081883 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 608 to 1088 481 to 1 A27P     481/481
(100 %)
2 diff
(99.6 %id)
AI082259 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 609 to 1093 496 to 12 exact AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 485/485
(100 %)
0 diff
(100 %id)
AA579855 adrenal adenoma, adrenal gland .l 611 to 1093 483 to 1 K10S L11F     483/483
(100 %)
2 diff
(99.6 %id)
BM987999 mixed .l 616 to 1087 489 to 19 exact AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 471/471
(100 %)
2 diff
(99.6 %id)
AW590686 pooled germ cell tumors .l 617 to 1087 471 to 1 W4C N18H     471/471
(100 %)
5 diff
(99.0 %id)
AA622483 colon, colon tumor RER+ .l 624 to 1088 470 to 1 P26T     470/470
(100 %)
23 diff
(95.2 %id)
AW779694 Kidney .l 632 to 1088 461 to 5 exact     457/461
(99 %)
0 diff
(100 %id)
AA633343 breast .l 634 to 1086 453 to 1 exact     453/453
(100 %)
0 diff
(100 %id)
AI279853 carcinoid, lung .l 645 to 1092 448 to 1 exact     448/448
(100 %)
0 diff
(100 %id)
AW613720 Kidney .l 654 to 1087 450 to 17   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 434/434
(100 %)
3 diff
(99.4 %id)
AW629403 pooled .l 655 to 1088 438 to 5       434/440
(98 %)
3 diff
(99.4 %id)
DB558198 hypothalamus .l 659 to 1087 1 to 441   AAA Submitted on the opposite strand 441/441
(100 %)
18 diff
(96.0 %id)
AA731259 germinal center B cell .l 670 to 1086 431 to 15   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 417/417
(100 %)
1 diff
(99.8 %id)
AI920989 adenocarcinoma, Pancreas .l 670 to 1087 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AA824618 germinal center B cell .l 675 to 1093 443 to 25   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 419/419
(100 %)
1 diff
(99.8 %id)
AA705645 heart .l 676 to 1084 409 to 1       409/409
(100 %)
1 diff
(99.8 %id)
AA446139   .l 676 to 1076 16 to 416   fully sequenced,   401/416
(96 %)
6 diff
(98.6 %id)
BX112726   .l 678 to 1076 1 to 399       399/399
(100 %)
0 diff
(100 %id)
BX333096 Neuroblastoma Cot 25-normalized .l 684 to 1030 366 to 18       349/577
(60 %)
8 diff
(98.7 %id)
AA826115 germinal center B cell .l 684 to 1086 417 to 15   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 403/403
(100 %)
0 diff
(100 %id)
AI285844 pooled .l 684 to 1088 406 to 2       405/406
(99 %)
0 diff
(100 %id)
AI209191   .l 691 to 1088 404 to 7       398/404
(98 %)
0 diff
(100 %id)
AW104545 pooled .l 691 to 1095 411 to 7       405/411
(98 %)
0 diff
(100 %id)
AI913130 Kidney .l 695 to 1087 393 to 1       393/426
(92 %)
0 diff
(100 %id)
AI985204 Kidney .l 696 to 1088 399 to 7       393/399
(98 %)
0 diff
(100 %id)
T19386   .l 707 to 1083 378 to 1       378/378
(100 %)
3 diff
(99.3 %id)
AI770151 2 pooled tumors (clear cell type), Kidney .l 714 to 1088 379 to 3       377/379
(99 %)
0 diff
(100 %id)
AI657091 pooled germ cell tumors .l 726 to 1087 376 to 15   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 362/362
(100 %)
3 diff
(99.2 %id)
AW001662 Kidney .l 728 to 1087 374 to 15   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 360/360
(100 %)
0 diff
(100 %id)
AW237853 Kidney .l 729 to 1095 367 to 1       367/367
(100 %)
1 diff
(99.8 %id)
AW589413 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .l 730 to 1095 371 to 6       366/371
(98 %)
0 diff
(100 %id)
BF509609   .l 741 to 1093 370 to 18   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 353/353
(100 %)
12 diff
(96.7 %id)
AI473360 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 742 to 1084 345 to 3       343/345
(99 %)
0 diff
(100 %id)
AI074673 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 747 to 1087 352 to 12   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 341/341
(100 %)
1 diff
(99.8 %id)
AA883352 pooled .l 755 to 1088 335 to 2       334/335
(99 %)
0 diff
(100 %id)
AA429805   .l 759 to 1083 325 to 1   fully sequenced,   325/325
(100 %)
0 diff
(100 %id)
CN363764 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 769 to 1087 1 to 319   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 319/319
(100 %)
0 diff
(100 %id)
AI769349 pooled .l 797 to 1085 310 to 22   AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 289/289
(100 %)
4 diff
(98.7 %id)
AI829615 pooled .l 799 to 1088 294 to 5       290/294
(98 %)
0 diff
(100 %id)
AI758276 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .l 806 to 1088 283 to 1       283/283
(100 %)
0 diff
(100 %id)
AI253766 Prostate .l 812 to 1093 282 to 1       282/282
(100 %)
0 diff
(100 %id)
FN091686 breast carcinoma .l 847 to 962 1 to 115       115/115
(100 %)
2 diff
(98.3 %id)
AA992874   .l 880 to 1095 217 to 2       216/218
(99 %)
0 diff
(100 %id)
FN120788 breast carcinoma .l 919 to 990 1 to 71       71/72
(98 %)
2 diff
(97.3 %id)
FN074763 breast carcinoma .l 941 to 1005 1 to 64       64/65
(98 %)
2 diff
(97.0 %id)
AI802282   .l 961 to 1093 133 to 1       133/133
(100 %)
0 diff
(100 %id)
AI678208 Prostate .m 1 to 418 429 to 12 exact tiling clone, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
DB250663 uterus .n 1 to 590 2 to 591   tiling clone, to resequence, capped   590/590
(100 %)
0 diff
(100 %id)
AI590276 Kidney .n 353 to 857 505 to 1 exact tiling clone,   505/505
(100 %)
0 diff
(100 %id)
DB351079 uterus .n 1383 to 1903 521 to 1   tiling clone, to resequence,   521/521
(100 %)
3 diff
(99.5 %id)
BX472149   .o-u 1 to 530 1 to 530   tiling clone,   530/530
(100 %)
2 diff
(99.7 %id)
AI373336 Kidney .o-u 126 to 580 455 to 1       455/455
(100 %)
0 diff
(100 %id)
R08123 liver and spleen .o-u 194 to 506 7 to 334   fully sequenced,   328/334
(98 %)
21 diff
(93.8 %id)
R08390 liver and spleen .o-u 200 to 292 1 to 93       93/93
(100 %)
1 diff
(99.0 %id)
BX110894 liver and spleen .o-u 201 to 797 1 to 597 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 597/597
(100 %)
0 diff
(100 %id)
T81158 liver and spleen .o-u 201 to 536 1 to 343       343/374
(91 %)
12 diff
(96.8 %id)
BE928139 colon .o-u 321 to 422 24 to 126       103/126
(81 %)
6 diff
(95.3 %id)
BE928144 colon .o-u 323 to 422 12 to 111       100/111
(90 %)
6 diff
(94.6 %id)
AA947051 Kidney, kidney tumor .o-u 395 to 807 413 to 1 exact tiling clone,   413/413
(100 %)
3 diff
(99.3 %id)
R08338 liver and spleen .o-u 428 to 785 365 to 1       365/397
(91 %)
16 diff
(96.0 %id)
R08124 liver and spleen .o-u 476 to 801 335 to 1   fully sequenced,   335/335
(100 %)
10 diff
(97.1 %id)
T81106 liver and spleen .o-u 603 to 786 185 to 2 N20D     184/185
(99 %)
0 diff
(100 %id)
TI_154043153   .p 1 to 803 879 to 85 exact tiling clone, AAA Possibly primed on the genome, locally A rich (30/30 A in genome downstream of last aligned base) 795/984
(80 %)
19 diff
(98.1 %id)
AL699807 human skeletal muscle .q 1 to 551 3 to 553 exact tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
CR743909 normal prostate, Prostate .r-u 1 to 508 1 to 508 exact tiling clone,   508/508
(100 %)
0 diff
(100 %id)
AA324508 brain, cerebellum .s-u 1 to 320 1 to 323 exact tiling clone,   323/323
(100 %)
3 diff
(99.1 %id)
AW964720   .s-u 2 to 495 1 to 495 exact tiling clone,   495/495
(100 %)
12 diff
(97.6 %id)
BX112913 placenta Gene DYNC2LI1, variant not shown         This clone was ignored    
AV696954 hepatocellular carcinoma Gene DYNC2LI1, variant not shown         Suspected internal deletion, this clone was ignored    
AV698019 hepatocellular carcinoma Gene DYNC2LI1, variant not shown         Suspected internal deletion, this clone was ignored    
AV684966 hepatocellular carcinoma Gene DYNC2LI1, variant not shown         Suspected internal deletion, this clone was ignored    
AV684967 hepatocellular carcinoma Gene DYNC2LI1, variant not shown         Suspected internal deletion, this clone was ignored    
AV696635 hepatocellular carcinoma Gene DYNC2LI1, variant not shown         Suspected internal deletion, this clone was ignored    
AV696051 hepatocellular carcinoma Gene DYNC2LI1, variant not shown         Suspected internal deletion, this clone was ignored    
R23165 placenta Gene DYNC2LI1, variant not shown         This clone was ignored    
R23166 placenta Gene DYNC2LI1, variant not shown         This clone was ignored    
AI658815 Prostate Gene DYNC2LI1, variant not shown         Suspected internal deletion, this clone was ignored    
BE567213 bladder, carcinoma, cell line Gene DYNC2LI1, variant not shown         This clone was ignored    
BF210237 bone marrow, from chronic myelogenous leukemia Gene DYNC2LI1, variant not shown         This clone was ignored    
BG704839 brain, hippocampus Gene DYNC2LI1, variant not shown         This clone was ignored    
CV570602 cornea, eye Gene DYNC2LI1, variant not shown              
BQ026289 placenta Gene DYNC2LI1, variant not shown         This clone was ignored    
BU753836 placenta Gene DYNC2LI1, variant not shown         This clone was ignored    
CB250664 Human Lung Epithelial cells, lung Gene DYNC2LI1, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o-u, .p, .q, .r-u, .s-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI